Literature DB >> 32068597

Evaluation of a child with suspected nephrolithiasis.

George S Reusz1, Adam Hosszu2, Eva Kis3.   

Abstract

PURPOSE OF REVIEW: As the incidence of nephrolithiasis in children doubles every 10 years it is becoming a common disease associated with significant morbidity along with considerable economic burden worldwide. The aim of this review is to summarize current data on the epidemiology and causes of renal stones in children and to provide a frame for the first clinical evaluation of a child with suspected nephrolithiasis. RECENT
FINDINGS: Dietary and environmental factors are the driving force of changing epidemiology. Diagnosis should be based on medical history, presenting signs, examination, first laboratory and radiological workup. Ultrasound should be the initial diagnostic imaging performed in pediatric patients while low-dose computed tomography is rarely necessary for management. Metabolic factors including hypercalciuria, hypocitraturia, low fluid intake as well as specific genetic diseases should be explored after the resolution of initial signs and symptoms.
SUMMARY: Appropriate initial evaluation, imaging technique, identification of risk factors and other abnormalities are essential for early diagnosis and prevention of stone-related morbidity in children with suspected nephrolithiasis.

Entities:  

Mesh:

Year:  2020        PMID: 32068597     DOI: 10.1097/MOP.0000000000000880

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  2 in total

1.  How to define and assess the clinically significant causes of hematuria in childhood.

Authors:  Orsolya Horváth; Attila J Szabó; George S Reusz
Journal:  Pediatr Nephrol       Date:  2022-10-19       Impact factor: 3.651

2.  Safety and efficacy of ultrasound-guided low-pressure perfusion mini-percutaneous nephrolithotomy in children aged 1-7 years: a retrospective observational study.

Authors:  Zhi Qiu; Quan-Bin Guo; Zakir Ablikim; Xu-Wen Shi; Jiang-Jiang Hou; Chang Chen; Mamat Hasanjan; Mamat Akbarjan; Abdukadir Anwar
Journal:  Int Urol Nephrol       Date:  2021-07-03       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.